|1.||Sugiyama, Haruo: 14 articles (02/2014 - 08/2002)|
|2.||Oka, Yoshihiro: 12 articles (02/2014 - 12/2002)|
|3.||Tsuboi, Akihiro: 11 articles (02/2014 - 12/2002)|
|4.||Oji, Yusuke: 10 articles (02/2014 - 12/2002)|
|5.||Kuzushima, Kiyotaka: 10 articles (09/2013 - 09/2004)|
|6.||Morishima, Yasuo: 9 articles (02/2015 - 06/2002)|
|7.||Nakamura, Yusuke: 9 articles (08/2014 - 12/2004)|
|8.||Barton, James C: 9 articles (01/2014 - 10/2002)|
|9.||Tokunaga, Katsushi: 9 articles (01/2014 - 01/2002)|
|10.||Takiguchi, Masafumi: 8 articles (07/2015 - 01/2002)|
08/01/2008 - "We demonstrated no statistical significant dependences between HCV infection course and efficacy of its treatment children and youth HLA A antigens. "
04/01/2002 - "In conclusion, this retrospective analysis shows that more HLA-A, -B compatibilities seems to be associated with an improved graft survival in patients after OLT for end-stage HBV infection."
10/01/2011 - "HLA-A, -B, -C, -DRB1 and -DQB1 genotyping were performed in 135 HCV-infected Brazilian patients among which 45 cleared HCV infection (cases) and 90 had persistent viral infection (controls). "
01/01/2009 - "HLA-A, -C, -DRB1 and -DQB1 genotyping were performed in a Midwestern American cohort of 105 HCV infected subjects among which 49 cleared HCV infection and 56 had persistent viral infection. "
08/01/2008 - "It is possible that course if HCV infection and efficacy of antiviral treatment are depended on HLA A antigens."
04/01/2014 - "The purpose of this study was to evaluate the potential associations between HLA-A, B, DRB1 gene and leukemia. "
03/01/2015 - "From a leukemia cell line, we identified a CDK4-derived peptide epitope, UNC-CDK4-1 (ALTPVVVTL), that bound HLA-A*02:01 with high affinity and could induce CD8⁺ T-cell responses in vitro. "
08/01/2014 - "We previously reported ESK1, a high avidity (Kd < 0.2 nmol/L), fully-human monoclonal antibody (mAb) specific for the WT1 RMF peptide/HLA-A*02:01 complex, which selectively bound and killed WT1(+) and HLA-A*02:01(+) leukemia and solid tumor cell lines. "
06/01/2013 - "A novel HLA-A allele, A*66:17 was revealed in a family of a leukemia patient during high-resolution HLA typing."
04/01/2013 - "[Correlation of HLA-A, B, DRB1 genes with leukemia]."
01/01/2012 - "To provide further evidence for the NPC susceptibility in the region near HLA-A locus based on other previous studies, we carried out a two-stage hospital-based case control association study including 535 sporadic NPC patients and 525 cancer-free control subjects from Guangdong, a high prevalence area of NPC in China. "
01/01/2012 - "Previous studies mainly focused on the expression of HLA-A in tumor cells. "
11/15/2005 - "The results of the present study indicate that HLA-A polymorphism is one of the host genetic factors that alter the risk for the development of cervical cancer in Chinese women."
10/01/2005 - "We investigated the frequency and relationship between HLA-A-B and HLA-A-B-DR haplotypes among women with cervical cancer/high-grade lesions (n=365) and cytologically normal population controls (n=681) within three cervical neoplasia studies in the US and Costa Rica. "
03/01/1991 - "In the current study, we have investigated T cell lines from patients who are heterozygous at HLA-A region locus, to determine the relative importance of each A-region allele in this MHC-restricted recognition of tumor. "
|4.||Melanoma (Melanoma, Malignant)
01/01/2013 - "We enrolled 33 stage III and IV HLA-A*02:01-positive patients with melanoma in this study, of whom 29 were evaluable for immunologic response. "
09/01/1996 - "This study was done to identify HLA-A*02 subtypes and their prevalence in two ancestrally different white melanoma populations. "
12/18/2015 - "Therefore, we analyzed by in vitro experiments the effect on antigen processing and recognition of a T210M exchange, which previously had been introduced into the melanoma gp100209-217tumor epitope to improve the HLA-A*02:01 binding and its immunogenicity. "
05/15/2015 - "The presentation of neoantigens by HLA-A*02:01 in human melanoma was confirmed by mass spectrometry. "
01/15/2014 - "This revealed that of the four HLA-A*02:06-restricted melanoma-associated T cell responses observed in this patient, two responses were underestimated and one was overlooked when using subtype-mismatched pMHC multimer collections. "
|5.||Graft vs Host Disease (Graft-Versus-Host Disease)
01/01/2014 - "Polymorphisms of HLA genes represent a major barrier to HSCT because HLA-A, -B, -C and DRB1 incompatibilities confer a higher risk of acute graft-versus-host disease (aGVHD) and mortality. "
06/10/2010 - "The risk of acute graft-versus-host disease (GVHD) of these HLA haplotypes was assessed with multivariate Cox regression in 712 patients transplanted from HLA fully (HLA-A, B, C, DRB1, DQB1, and DPB1) matched unrelated donors. "
10/01/2004 - "We therefore examined the effects of HLA matching (low or high resolution or both) on engraftment, graft-versus-host disease (GVHD), and mortality in 1874 donor-recipient pairs retrospectively typed at high resolution for HLA-A, -B, -C, -DRB1, -DQ, and -DP. "
04/01/1995 - "Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings."
02/01/1989 - "Implication of a gene distal to HLA-A in the etiology of graft-versus-host disease."
|2.||HLA-DRB1 antigen (HLA DRB1)
|3.||HLA-B Antigens (HLA-B)
|4.||HLA-C Antigens (HLA-C)
|6.||HLA-DQB1 antigen (HLA DQB1)
|7.||HLA-A Antigens (HLA-A)
|8.||Muromonab-CD3 (Muromonab CD3)
|10.||Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
|2.||Transplantation (Transplant Recipients)
|3.||Drug Therapy (Chemotherapy)
|4.||Bone Marrow Transplantation (Transplantation, Bone Marrow)
|5.||Homologous Transplantation (Allograft)